THE PPM1D ENCODED PHOSPHATASE WIP1 IS A NOVEL ONCOGENE AND POTENTIAL THERAPEUTIC TARGET IN NEUROBLASTOMA AND MEDULLOBLASTOMA

被引：0
|
作者：
Milosevic, J. [1 ]
Treis, D. [1 ]
Malin, M. [1 ]
Fransson, S. [2 ]
Sveinbjornsson, B. [3 ]
Eissler, N. [1 ]
Baryawno, N. [1 ]
Tanino, K. [4 ]
Selivanova, G. [5 ]
Sakaguchi, K. [4 ]
Martinsson, T. [2 ]
Johnsen, J. I. [1 ]
Kogner, P. [1 ]
机构：
[1] Karolinska Inst, Womens & Childrens Hlth, Stockholm, Sweden
[2] Gothenburg Univ, Dept Clin Genet, Inst Biomed, Gothenburg, Sweden
[3] Univ Tromso, Div Immunol IMB, Tromso, Norway
[4] Hokkaido Univ, Fac Sci, Biol Chem Lab, Dept Chem, Sapporo, Hokkaido 060, Japan
[5] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-382
引用
收藏
页码：S332 / S332
页数：1
相关论文
共 50 条
  • [41] A novel assay for screening WIP1 phosphatase substrates in nuclear extracts
    Storchova, Radka
    Burdova, Kamila
    Palek, Matous
    Medema, Rene H.
    Macurek, Libor
    FEBS JOURNAL, 2021, 288 (20) : 6035 - 6051
  • [42] Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation
    Ogasawara, Sari
    Kiyota, Yuhei
    Chuman, Yoshiro
    Kowata, Ayano
    Yoshimura, Fumihiko
    Tanino, Keiji
    Kamada, Rui
    Sakaguchi, Kazuyasu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (19) : 6246 - 6249
  • [43] LSD1 is a novel therapeutic target in neuroblastoma (NB) and medulloblastoma (MB)
    Pajtler, K.
    Thor, T.
    Baumann, M.
    Heukamp, L.
    Lim, S.
    Kirfel, J.
    Schramm, A.
    Kuhfittig-Kulle, S.
    Metzger, E.
    Buettner, R.
    Schuele, R.
    Eggert, A.
    Schulte, J. H.
    EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (03) : 381 - 381
  • [44] NF-kappaB is a novel transcriptional regulator of the oncogenic Wip1 phosphatase
    Lowe, Julie
    Yang, Qian
    Cha, Hyukjin
    Fornace, Albert
    CANCER RESEARCH, 2009, 69
  • [45] Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis
    Marcellino, Bridget K.
    Clementelli, Cara
    Beaumont, Kristin
    Schaniel, Christoph
    Lu, Min
    Chen, Karie
    Russel, Adena
    Mohammad, Ayman
    Nathan, Daniel I.
    Aronin, Jake
    Shih, Alan H.
    Sebra, Robert
    Hoffman, Ronald
    BLOOD, 2022, 140
  • [46] PPM1D MUTATION MEDIATES TUMORIGENESIS AND IS A THERAPEUTIC TARGET IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Akamandisa, Mwangala
    Nie, Kai
    Wen, Jing
    Nahta, Rita
    Hambardzumyan, Dolores
    Castellino, Robert
    NEURO-ONCOLOGY, 2018, 20 : 61 - 61
  • [47] Novel chemical inhibitors specific for p53-inducible protein phosphatase PPM1D
    Yagi, Hiroaki
    Chuman, Yoshiro
    Yoshimura, Fumihiko
    Tanino, Keiji
    Sakaguchi, Kazuyasu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [48] Dual roles for the phosphatase PPM1D in regulating progesterone receptor function
    Proia, DA
    Nannenga, BW
    Donehower, LA
    Weigel, NL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) : 7089 - 7101
  • [49] Effects of RNAi based downregulation of PPM1D phosphatase in breast cancer
    Rauta, Jenita
    Alarmo, Emma-Leena
    Karhu, Ritva
    Kallioniemi, Anne
    CANCER RESEARCH, 2006, 66 (08)
  • [50] Characterization of the active site and a unique uncompetitive inhibitor of the PPM1-type protein phosphatase PPM1D
    Chuman, Yoshiro
    Yagi, Hiroaki
    Fukuda, Tomohiko
    Nomura, Takao
    Matsukizono, Miho
    Shimohigashi, Yasuyuki
    Sakaguchi, Kazuyasu
    PROTEIN AND PEPTIDE LETTERS, 2008, 15 (09): : 938 - 948
12345